Agape ATP (ATPC) Competitors $1.28 0.00 (0.00%) Closing price 03:54 PM EasternExtended Trading$1.30 +0.02 (+1.56%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ATPC vs. XGN, DCGO, CORBF, SERA, QIPT, BNR, PIII, BDSX, EUDA, and BMGLShould you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Burning Rock Biotech (BNR), P3 Health Partners (PIII), Biodesix (BDSX), EUDA Health (EUDA), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry. Agape ATP vs. Its Competitors Exagen DocGo Global Cord Blood Sera Prognostics Quipt Home Medical Burning Rock Biotech P3 Health Partners Biodesix EUDA Health Basel Medical Group Exagen (NASDAQ:XGN) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment. Do analysts prefer XGN or ATPC? Exagen currently has a consensus price target of $12.00, indicating a potential upside of 24.35%. Given Exagen's stronger consensus rating and higher possible upside, equities research analysts clearly believe Exagen is more favorable than Agape ATP.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00Agape ATP 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable valuation and earnings, XGN or ATPC? Agape ATP has lower revenue, but higher earnings than Exagen. Exagen is trading at a lower price-to-earnings ratio than Agape ATP, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExagen$55.64M3.82-$15.11M-$0.89-10.84Agape ATP$1.32M48.49-$2.47M-$0.41-3.12 Does the media prefer XGN or ATPC? In the previous week, Exagen had 15 more articles in the media than Agape ATP. MarketBeat recorded 17 mentions for Exagen and 2 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.97 beat Exagen's score of 0.91 indicating that Agape ATP is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exagen 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is XGN or ATPC more profitable? Exagen has a net margin of -28.85% compared to Agape ATP's net margin of -183.13%. Agape ATP's return on equity of -20.32% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Exagen-28.85% -130.38% -34.69% Agape ATP -183.13%-20.32%-18.55% Which has more risk & volatility, XGN or ATPC? Exagen has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.98, meaning that its share price is 198% less volatile than the S&P 500. Do institutionals and insiders have more ownership in XGN or ATPC? 75.3% of Exagen shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 12.6% of Exagen shares are owned by insiders. Comparatively, 9.7% of Agape ATP shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryExagen beats Agape ATP on 9 of the 16 factors compared between the two stocks. Get Agape ATP News Delivered to You Automatically Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATPC vs. The Competition Export to ExcelMetricAgape ATPMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$64.01M$10.78B$5.76B$10.29BDividend YieldN/A1.89%5.74%4.63%P/E Ratio-3.1221.3876.8626.97Price / Sales48.4931.07540.67127.61Price / CashN/A24.4337.1760.63Price / Book2.673.4513.836.37Net Income-$2.47M$210.63M$3.29B$271.46M7 Day Performance-4.41%0.12%0.93%2.35%1 Month Performance-2.29%1.44%5.31%7.78%1 Year Performance-36.95%-8.60%84.25%32.27% Agape ATP Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATPCAgape ATP0.7662 of 5 stars$1.28flatN/A-37.6%$64.01M$1.32M-3.1240News CoverageXGNExagen4.5984 of 5 stars$9.11-2.1%$12.00+31.7%+231.0%$204.85M$55.64M-10.24220Analyst RevisionDCGODocGo2.3914 of 5 stars$1.53-1.9%$3.59+134.6%-58.5%$152.58M$616.55M-8.054,407News CoveragePositive NewsCORBFGlobal Cord BloodN/A$1.00flatN/AN/A$121.55M$196.12M0.001,200Gap DownSERASera Prognostics1.4954 of 5 stars$3.08-0.6%N/A-59.6%$116.79M$80K-3.62120QIPTQuipt Home Medical1.3318 of 5 stars$2.63-1.1%$3.15+19.8%-7.3%$115.56M$245.91M-10.961,200BNRBurning Rock Biotech0.659 of 5 stars$8.49-2.5%N/A+138.3%$93.73M$70.67M-4.471,390PIIIP3 Health Partners3.026 of 5 stars$8.38-2.9%$16.25+93.9%-64.4%$62M$1.50B-0.18500Positive NewsGap DownTrading HaltedBDSXBiodesix3.4196 of 5 stars$6.56-13.7%$35.00+433.5%-82.7%$55.72M$71.32M-1.13220Stock SplitGap DownEUDAEUDA Health0.2936 of 5 stars$1.10+3.8%N/A-67.7%$39.39M$4.01M0.002Negative NewsGap UpBMGLBasel Medical GroupN/A$2.07+4.5%N/AN/A$36.54MN/A0.0036News CoverageGap Up Related Companies and Tools Related Companies XGN Competitors DCGO Competitors CORBF Competitors SERA Competitors QIPT Competitors BNR Competitors PIII Competitors BDSX Competitors EUDA Competitors BMGL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATPC) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agape ATP Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Agape ATP With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
